{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:37:14Z","timestamp":1792003034935,"version":"4.4.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40123-025-01129-8","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:00:55Z","timestamp":1743271255000},"page":"815-833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Optimizing Diagnosis and Management of Dry Eye Disease: A Practical Framework for Hong Kong"],"prefix":"10.1007","volume":"14","author":[{"given":"Douglas","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendrick","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin H.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7265-2444","authenticated-orcid":false,"given":"Arthur","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"9","key":"1129_CR1","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0161-6420(97)30125-0","volume":"104","author":"OD Schein","year":"1997","unstructured":"Schein OD, Tielsch JM, Mun\u00f5z B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology. 1997;104(9):1395\u2013401.","journal-title":"Ophthalmology"},{"issue":"6","key":"1129_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","volume":"124","author":"OD Schein","year":"1997","unstructured":"Schein OD, Mu\u00f1oz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124(6):723\u20138.","journal-title":"Am J Ophthalmol"},{"key":"1129_CR3","doi-asserted-by":"crossref","unstructured":"[No Authors Listed] The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):93\u2013107.","DOI":"10.1016\/S1542-0124(12)70082-4"},{"issue":"6","key":"1129_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S0161-6420(98)96016-X","volume":"105","author":"CA McCarty","year":"1998","unstructured":"McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105(6):1114\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"1129_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/09286580802228509","volume":"16","author":"E Viso","year":"2009","unstructured":"Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol. 2009;16(1):15\u201321.","journal-title":"Ophthalmic Epidemiol"},{"issue":"10","key":"1129_CR6","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/01.ico.0000244875.92879.1a","volume":"25","author":"K Lekhanont","year":"2006","unstructured":"Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25(10):1162\u20137.","journal-title":"Cornea"},{"issue":"6","key":"1129_CR7","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1111\/aos.12174","volume":"92","author":"F Malet","year":"2014","unstructured":"Malet F, Le Goff M, Colin J, et al. Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol. 2014;92(6):e429\u201336.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"1129_CR8","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1136\/bjophthalmol-2014-305201","volume":"98","author":"J Vehof","year":"2014","unstructured":"Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol. 2014;98(12):1712\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1129_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","volume":"118","author":"SE Moss","year":"2000","unstructured":"Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1129_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1159\/000525696","volume":"65","author":"Y Cai","year":"2022","unstructured":"Cai Y, Wei J, Zhou J, Zou W. Prevalence and incidence of dry eye disease in Asia: a systematic review and meta-analysis. Ophthalmic Res. 2022;65(6):647\u201358.","journal-title":"Ophthalmic Res"},{"issue":"6","key":"1129_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archophthalmol.2009.103","volume":"127","author":"DA Schaumberg","year":"2009","unstructured":"Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians\u2019 Health Studies. Arch Ophthalmol. 2009;127(6):763\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1129_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajo.2019.01.026","volume":"202","author":"R Dana","year":"2019","unstructured":"Dana R, Bradley JL, Guerin A, et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States Health Care System. Am J Ophthalmol. 2019;202:47\u201354.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1129_CR13","first-page":"92","volume":"49","author":"Z Fan","year":"2023","unstructured":"Fan Z, Du Y, Tang C, et al. Awareness, prevalence, and knowledge of dry eye among internet professionals: a cross-sectional study in China. Eye Contact Lens. 2023;49(3):92\u20137.","journal-title":"Eye Contact Lens"},{"issue":"3","key":"1129_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"1","key":"1129_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-021-02233-6","volume":"22","author":"S Zhao","year":"2022","unstructured":"Zhao S, Le Q. Analysis of the first tear film break-up point in Sj\u00f6gren\u2019s syndrome and non-Sj\u00f6gren\u2019s syndrome dry eye patients. BMC Ophthalmol. 2022;22(1):1.","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"1129_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000267188","volume":"24","author":"G Petroutsos","year":"1992","unstructured":"Petroutsos G, Paschides CA, Karakostas KX, Psilas K. Diagnostic tests for dry eye disease in normals and dry eye patients with and without Sj\u00f6gren\u2019s syndrome. Ophthalmic Res. 1992;24(6):326\u201331.","journal-title":"Ophthalmic Res"},{"issue":"10 Suppl","key":"1129_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ophtha.2012.06.064","volume":"119","author":"GN Foulks","year":"2012","unstructured":"Foulks GN, Nichols KK, Bron AJ, Holland EJ, McDonald MB, Nelson JD. Improving awareness, identification, and management of meibomian gland dysfunction. Ophthalmology. 2012;119(10 Suppl):S1-12.","journal-title":"Ophthalmology"},{"issue":"4","key":"1129_CR18","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","volume":"52","author":"KK Nichols","year":"2011","unstructured":"Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Investig Ophthalmol Vis Sci. 2011;52(4):1922\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1129_CR19","doi-asserted-by":"crossref","unstructured":"Tsubota K, Yokoi N, Watanabe H, et al., Members of The Asia Dry Eye Society. A new perspective on dry eye classification: proposal by the Asia Dry Eye Society. Eye Contact Lens. 2020;46(Suppl 1(1)):S2\u201313 (Erratum in: Eye Contact Lens. 2020;46(5):e39).","DOI":"10.1097\/ICL.0000000000000643"},{"issue":"2","key":"1129_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10384-018-00645-4","volume":"63","author":"N Yokoi","year":"2019","unstructured":"Yokoi N, Georgiev GA. Tear-film-oriented diagnosis for dry eye. Jpn J Ophthalmol. 2019;63(2):127\u201336.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"1129_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","volume":"15","author":"DA Sullivan","year":"2017","unstructured":"Sullivan DA, Rocha EM, Aragona P, et al. TFOS DEWS II sex, gender, and hormones report. Ocul Surf. 2017;15(3):284\u2013333.","journal-title":"Ocul Surf"},{"issue":"6","key":"1129_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ajo.2011.11.030","volume":"153","author":"B Pouyeh","year":"2012","unstructured":"Pouyeh B, Viteri E, Feuer W, et al. Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population. Am J Ophthalmol. 2012;153(6):1061-66.e3.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1129_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovi\u0107","year":"2007","unstructured":"Miljanovi\u0107 B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143(3):409\u201315.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1129_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","volume":"1","author":"M Uchino","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1(2):51\u20137.","journal-title":"Curr Ophthalmol Rep"},{"key":"1129_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jtos.2021.04.011","volume":"21","author":"JS Wolffsohn","year":"2021","unstructured":"Wolffsohn JS, Trav\u00e9Huarte S, Jones L, Craig JP, Wang MTM. Clinical practice patterns in the management of dry eye disease: a TFOS international survey. Ocul Surf. 2021;21:78\u201386.","journal-title":"Ocul Surf"},{"issue":"1","key":"1129_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OPTH.S1496","volume":"2","author":"G Savini","year":"2008","unstructured":"Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2(1):31\u201355.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1129_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/aos.12012","volume":"92","author":"BD Sullivan","year":"2014","unstructured":"Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161\u20136.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1129_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.optom.2020.10.002","volume":"14","author":"CW McMonnies","year":"2021","unstructured":"McMonnies CW. Why the symptoms and objective signs of dry eye disease may not correlate. J Optom. 2021;14(1):3\u201310.","journal-title":"J Optom"},{"issue":"8","key":"1129_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005296","volume":"4","author":"R Hua","year":"2014","unstructured":"Hua R, Yao K, Hu Y, Chen L. Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population-based analysis. BMJ Open. 2014;4(8): e005296.","journal-title":"BMJ Open"},{"issue":"2","key":"1129_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajo.2013.10.014","volume":"157","author":"M Uchino","year":"2014","unstructured":"Uchino M, Uchino Y, Dogru M, et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol. 2014;157(2):294\u2013300.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1129_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101450","volume":"45","author":"P Bilkhu","year":"2022","unstructured":"Bilkhu P, Sivardeen Z, Chen C, et al. Patient-reported experience of dry eye management: an international multicentre survey. Cont Lens Anterior Eye. 2022;45(1): 101450.","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"1129_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/21642850.2020.1770093","volume":"8","author":"M Toth","year":"2020","unstructured":"Toth M, Joki\u0107-Begi\u0107 N. Psychological contribution to understanding the nature of dry eye disease: a cross-sectional study of anxiety sensitivity and dry eyes. Health Psychol Behav Med. 2020;8(1):202\u201319.","journal-title":"Health Psychol Behav Med"},{"issue":"2 Suppl","key":"1129_CR33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron AJ, Tomlinson A, Foulks GN, et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014;12(2 Suppl):S1-31.","journal-title":"Ocul Surf"},{"key":"1129_CR34","doi-asserted-by":"crossref","unstructured":"Tong L, Lim L, Tan D, Heng WJ, Lim J, Chan C, Arundhati A, Tan A, Corneal Subspecialty Workgroup, College of Ophthalmology, Academy of Medicine, Singapore. Assessment and management of dry eye disease and meibomian gland dysfunction: providing a Singapore framework. Asia Pac J Ophthalmol (Phila). 2021;10(6):530\u201341.","DOI":"10.1097\/APO.0000000000000417"},{"issue":"3","key":"1129_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u201374.","journal-title":"Ocul Surf"},{"issue":"8","key":"1129_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/ICO.0000000000000173","volume":"33","author":"CF Henrich","year":"2014","unstructured":"Henrich CF, Ramulu PY, Akpek EK. Association of dry eye and inflammatory systemic diseases in a tertiary care-based sample. Cornea. 2014;33(8):819\u201325.","journal-title":"Cornea"},{"issue":"4","key":"1129_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1542-0124(11)70034-9","volume":"9","author":"J Wong","year":"2011","unstructured":"Wong J, Lan W, Ong LM, Tong L. Non-hormonal systemic medications and dry eye. Ocul Surf. 2011;9(4):212\u201326.","journal-title":"Ocul Surf"},{"key":"1129_CR38","volume":"1","author":"SP Phadatare","year":"2015","unstructured":"Phadatare SP, Momin M, Nighojkar P, Askarkar S, Singh KK. A comprehensive review on dry eye disease: diagnosis, medical management, recent developments, and future challenges. Adv Pharm. 2015;1: 704946.","journal-title":"Adv Pharm"},{"issue":"6","key":"1129_CR39","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00003226-200108000-00011","volume":"20","author":"CG Begley","year":"2001","unstructured":"Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20(6):610\u20138.","journal-title":"Cornea"},{"issue":"12","key":"1129_CR40","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/bjo.86.12.1347","volume":"86","author":"AJ Lee","year":"2002","unstructured":"Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population-based study in Indonesia. Br J Ophthalmol. 2002;86(12):1347\u201351.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1129_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18773\/austprescr.2018.048","volume":"41","author":"Q Findlay","year":"2018","unstructured":"Findlay Q, Reid K. Dry eye disease: when to treat and when to refer. Aust Prescr. 2018;41(5):160\u20133.","journal-title":"Aust Prescr"},{"issue":"5","key":"1129_CR42","first-page":"71","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112(5):71\u201381.","journal-title":"Dtsch Arztebl Int"},{"key":"1129_CR43","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/OPTH.S480223","volume":"18","author":"P Mu\u00f1oz-Villegas","year":"2024","unstructured":"Mu\u00f1oz-Villegas P, Garc\u00eda-S\u00e1nchez G, Jauregui-Franco RO, Quirarte-Justo S, S\u00e1nchez-R\u00edos A, Olvera-Monta\u00f1o O. Influence of environmental factors with clinical signs and symptoms in the management of dry eye disease. Clin Ophthalmol. 2024;18:2439\u201351.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"1129_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3341\/kjo.2023.0077","volume":"37","author":"MS Song","year":"2023","unstructured":"Song MS, Lee Y, Paik HJ, Kim DH. A Comprehensive analysis of the influence of temperature and humidity on dry eye disease. Korean J Ophthalmol. 2023;37(6):501\u20139.","journal-title":"Korean J Ophthalmol"},{"issue":"7","key":"1129_CR45","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640\u201350.","journal-title":"Cornea"},{"issue":"7","key":"1129_CR46","first-page":"2856","volume":"65","author":"B Guo","year":"2024","unstructured":"Guo B, Chan KY, Tse J, et al. Exploring the prevalence of dry eye disease in Hong Kong population. Investig Ophthalmol Vis Sci. 2024;65(7):2856.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"1129_CR47","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/02713689609008906","volume":"15","author":"JC Mainstone","year":"1996","unstructured":"Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res. 1996;15(6):653\u201361.","journal-title":"Curr Eye Res"},{"key":"1129_CR48","doi-asserted-by":"crossref","unstructured":"Wahyu T. Examination for Dry Eyes. In: Dry eye syndrome. IntechOpen. 2021. https:\/\/www.intechopen.com\/chapters\/77448. Accessed 6 Feb 2025.","DOI":"10.5772\/intechopen.98800"},{"issue":"4","key":"1129_CR49","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.4103\/ijo.IJO_2137_22","volume":"71","author":"SP Srinivas","year":"2023","unstructured":"Srinivas SP, Rao SK. Ocular surface staining: current concepts and techniques. Indian J Ophthalmol. 2023;71(4):1080\u20139.","journal-title":"Indian J Ophthalmol"},{"key":"1129_CR50","doi-asserted-by":"crossref","unstructured":"Jeng BH. 7\u2014Diagnostic techniques in ocular surface disease. In: Ocular surface disease: cornea, conjunctiva and tear film. In: Holland EJ, Mannis MJ, Barry Lee W. W.B. Saunders; 2013. pp. 47\u201354.","DOI":"10.1016\/B978-1-4557-2876-3.00007-9"},{"key":"1129_CR51","doi-asserted-by":"crossref","unstructured":"Baudouin C, Aragona P, Van Setten G, et al., ODISSEY European Consensus Group members. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168\u201376.","DOI":"10.1136\/bjophthalmol-2013-304619"},{"key":"1129_CR52","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2147\/OPTH.S351898","volume":"16","author":"A Rodriguez-Garcia","year":"2022","unstructured":"Rodriguez-Garcia A, Babayan-Sosa A, Ramirez-Miranda A, et al. A practical approach to severity classification and treatment of dry eye disease: a proposal from the Mexican Dry Eye Disease Expert Panel. Clin Ophthalmol. 2022;16:1331\u201355.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"1129_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628.","journal-title":"Ocul Surf"},{"issue":"6","key":"1129_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1475-1313.2009.00683.x","volume":"29","author":"MJ Doughty","year":"2009","unstructured":"Doughty MJ, Glavin S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review. Ophthalmic Physiol Opt. 2009;29(6):573\u201383.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1129_CR55","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"issue":"23","key":"1129_CR56","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.3390\/jcm12237301","volume":"12","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, Martinez-Perez C, Alvarez-Peregrina C, et al. Trehalose and dry eye disease: a comprehensive systematic review of randomized controlled trials. J Clin Med. 2023;12(23):7301.","journal-title":"J Clin Med"},{"key":"1129_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109168","volume":"222","author":"I Abbate","year":"2022","unstructured":"Abbate I, Zappulla C, Santonocito M, et al. Preclinical study of a new matrix to help the ocular surface in dry eye disease. Exp Eye Res. 2022;222: 109168.","journal-title":"Exp Eye Res"},{"issue":"11","key":"1129_CR58","first-page":"b13","volume":"12","author":"H Panchal","year":"2024","unstructured":"Panchal H, Parihar L, Kumari T, Goswami M, Sharma K. Pharmacological actions and different mechanisms of allantoin. A review JETIR. 2024;12(11):b13\u201332.","journal-title":"A review JETIR"},{"issue":"2","key":"1129_CR59","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/pharmaceutics16020236","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Lin N, Li JM, et al. Ectoine, from a natural bacteria protectant to a new treatment of dry eye disease. Pharmaceutics. 2024;16(2):236.","journal-title":"Pharmaceutics"},{"key":"1129_CR60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2017.05.022","volume":"180","author":"N Yokoi","year":"2017","unstructured":"Yokoi N, Georgiev GA, Kato H, et al. Classification of fluorescein breakup patterns: a novel method of differential diagnosis for dry eye. Am J Ophthalmol. 2017;180:72\u201385.","journal-title":"Am J Ophthalmol"},{"key":"1129_CR61","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.2147\/OPTH.S384819","volume":"16","author":"C Matossian","year":"2022","unstructured":"Matossian C, Crowley M, Periman L, Sorkin S. Personalized management of dry eye disease: beyond artificial tears. Clin Ophthalmol. 2022;16:3911\u20138.","journal-title":"Clin Ophthalmol"},{"key":"1129_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jtos.2023.10.001","volume":"30","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, De-Hita-Cantalejo C, S\u00e1nchez-Gonz\u00e1lez MC, et al. Perfluorohexyloctane in dry eye disease: a systematic review of its efficacy and safety as a novel therapeutic agent. Ocul Surf. 2023;30:254\u201362.","journal-title":"Ocul Surf"},{"issue":"1","key":"1129_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1517\/13543784.13.1.47","volume":"13","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Yerxa B, Kellerman DJ. Diquafosol tetrasodium: a novel dry eye therapy. Expert Opin Investig Drugs. 2004;13(1):47\u201354.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"1129_CR64","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jtos.2017.03.005","volume":"15","author":"S Fukuoka","year":"2017","unstructured":"Fukuoka S, Arita R. Increase in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes. Ocul Surf. 2017;15(4):730\u20135.","journal-title":"Ocul Surf"},{"issue":"1","key":"1129_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12886-023-03004-1","volume":"23","author":"Y Eom","year":"2023","unstructured":"Eom Y, Chung SH, Chung TY, et al. Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial. BMC Ophthalmol. 2023;23(1):343.","journal-title":"BMC Ophthalmol"},{"issue":"22","key":"1129_CR66","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.3390\/jcm12227155","volume":"12","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez MC, De-Hita-Cantalejo C, Guti\u00e9rrez-S\u00e1nchez E, Rocha-de-Lossada C, S\u00e1nchez-Gonz\u00e1lez JM. The efficacy and safety of rebamipide ophthalmic suspension (OPC-12759) in patients with dry eye disease: a systematic review of randomized controlled trials. J Clin Med. 2023;12(22):7155.","journal-title":"J Clin Med"},{"issue":"8","key":"1129_CR67","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jamaophthalmol.2014.431","volume":"132","author":"S Kase","year":"2014","unstructured":"Kase S, Shinohara T, Kase M. Effect of topical rebamipide on human conjunctival goblet cells. JAMA Ophthalmol. 2014;132(8):1021\u20132.","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"1129_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102154","volume":"47","author":"FA Maulvi","year":"2024","unstructured":"Maulvi FA, Desai DT, Kalaiselvan P, et al. Lipid-based eye drop formulations for the management of evaporative dry eyes. Cont Lens Anterior Eye. 2024;47(3): 102154.","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"1129_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2211-5056.369606","volume":"13","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Kolluru A, Beglarian T. Dry eye disease: a review of anti-inflammatory therapies. Taiwan J Ophthalmol. 2023;13(1):3\u201312.","journal-title":"Taiwan J Ophthalmol"},{"key":"1129_CR70","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138(3):444\u201357.","DOI":"10.1016\/j.ajo.2004.04.052"},{"key":"1129_CR71","doi-asserted-by":"crossref","unstructured":"Liu SH, Saldanha IJ, Abraham AG, et al. Topical corticosteroids for dry eye. Cochrane Database Syst Rev. 2022;10(10):CD015070.","DOI":"10.1002\/14651858.CD015070.pub2"},{"issue":"5","key":"1129_CR72","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0002-9394(70)90492-7","volume":"70","author":"MM Knopf","year":"1970","unstructured":"Knopf MM. A double-blind study of fluorometholone. Am J Ophthalmol. 1970;70(5):739\u201340.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1129_CR73","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/archopht.126.8.1046","volume":"126","author":"HD Perry","year":"2008","unstructured":"Perry HD, Solomon R, Donnenfeld ED, et al. Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch Ophthalmol. 2008;126(8):1046\u201350.","journal-title":"Arch Ophthalmol"},{"key":"1129_CR74","doi-asserted-by":"crossref","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107(4):631\u20139 (Erratum in: Ophthalmology 2000 Jul;107(7):1220).","DOI":"10.1016\/S0161-6420(99)00176-1"},{"issue":"2\u20133","key":"1129_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","volume":"47","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47(2\u20133):119\u201325.","journal-title":"Immunopharmacology"},{"issue":"4","key":"1129_CR76","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1167\/iovs.11-8829","volume":"53","author":"C Di Tommaso","year":"2012","unstructured":"Di Tommaso C, Valamanesh F, Miller F, et al. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Investig Ophthalmol Vis Sci. 2012;53(4):2292\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"1129_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","volume":"65","author":"S Sabeti","year":"2020","unstructured":"Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Surv Ophthalmol. 2020;65(2):205\u201317.","journal-title":"Surv Ophthalmol"},{"key":"1129_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajo.2016.06.025","volume":"169","author":"R Arita","year":"2016","unstructured":"Arita R, Minoura I, Morishige N, et al. Development of definitive and reliable grading scales for meibomian gland dysfunction. Am J Ophthalmol. 2016;169:125\u201337.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1129_CR79","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1167\/iovs.16-19251","volume":"57","author":"JW Jung","year":"2016","unstructured":"Jung JW, Park SY, Kim JS, Kim EK, Seo KY, Kim TI. Analysis of factors associated with the tear film lipid layer thickness in normal eyes and patients with dry eye syndrome. Investig Ophthalmol Vis Sci. 2016;57(10):4076\u201383.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"1129_CR80","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/ICO.0b013e3182a7f3e1","volume":"32","author":"D Finis","year":"2013","unstructured":"Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for meibomian gland dysfunction. Cornea. 2013;32(12):1549\u201353.","journal-title":"Cornea"},{"issue":"5","key":"1129_CR81","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1167\/iovs.05-0802","volume":"47","author":"M Dogru","year":"2006","unstructured":"Dogru M, Ishida K, Matsumoto Y, Goto E, Ishioka M, Kojima T, Goto T, Saeki M, Tsubota K. Strip meniscometry: a new and simple method of tear meniscus evaluation. Investig Ophthalmol Vis Sci. 2006;47(5):1895\u2013901.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"1129_CR82","first-page":"525","volume":"14","author":"CA Blackie","year":"2016","unstructured":"Blackie CA, Kowlitt MS, Akpek EK, Holland EJ, Donnenfield ED. Long-term (12-month) benefits of a single intense pulsed light (IPL) treatment followed by meibomian gland expression (MGX) for meibomian gland dysfunction. Ocul Surf. 2016;14(4):525\u201334.","journal-title":"Ocul Surf"},{"issue":"8","key":"1129_CR83","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s40123-024-00976-1","volume":"13","author":"CA Blackie","year":"2024","unstructured":"Blackie CA, Murakami D, Donnenfeld E, Oliff HS. Vectored thermal pulsation as a treatment for meibomian gland dysfunction: a review spanning 15 years. Ophthalmol Ther. 2024;13(8):2083\u2013123.","journal-title":"Ophthalmol Ther"},{"key":"1129_CR84","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/OPTO.S217639","volume":"11","author":"G Giannaccare","year":"2019","unstructured":"Giannaccare G, Taroni L, Senni C, Scorcia V. Intense pulsed light therapy in the treatment of meibomian gland dysfunction: current perspectives. Clin Optom (Auckl). 2019;11:113\u201326.","journal-title":"Clin Optom (Auckl)"},{"issue":"1","key":"1129_CR85","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/ICL.0000000000000958","volume":"49","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, Gargallo-Mart\u00ednez B, S\u00e1nchez-Gonz\u00e1lez MC, S\u00e1nchez-Gonz\u00e1lez JM. Intense pulse light combined with low-level light therapy in dry eye disease: a systematic review. Eye Contact Lens. 2023;49(1):8\u201313.","journal-title":"Eye Contact Lens"},{"issue":"6","key":"1129_CR86","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/asj\/sjab025","volume":"41","author":"GE Glass","year":"2021","unstructured":"Glass GE. Photobiomodulation: the clinical applications of low-level light therapy. Aesthet Surg J. 2021;41(6):723\u201338.","journal-title":"Aesthet Surg J"},{"issue":"3","key":"1129_CR87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OPX.0000000000001354","volume":"96","author":"JS Siddireddy","year":"2019","unstructured":"Siddireddy JS, Tan J, Vijay AK, Willcox MDP. The effect of microblepharon exfoliation on clinical correlates of contact lens discomfort. Optom Vis Sci. 2019;96(3):187\u201399.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"1129_CR88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/APO.0000000000000607","volume":"12","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, Gargallo-Mart\u00ednez B, Guti\u00e9rrez-Ortega R, S\u00e1nchez-Gonz\u00e1lez JM. Eyelid exfoliation treatment efficacy and safety in dry eye disease, blepharitis, and contact lens discomfort patients: a systematic review. Asia Pac J Ophthalmol (Phila). 2023;12(3):315\u201325.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"1129_CR89","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40123-023-00868-w","volume":"13","author":"A Ballesteros-S\u00e1nchez","year":"2024","unstructured":"Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez JM, Tedesco GR, et al. Efficacy and safety of quantum molecular resonance electrotherapy in patients with aqueous-deficient, evaporative and mixed-type dry eye: a randomized interventional study. Ophthalmol Ther. 2024;13(2):495\u2013507.","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"1129_CR90","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/opo.12888","volume":"41","author":"EB Papas","year":"2021","unstructured":"Papas EB. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254\u201366.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1129_CR91","doi-asserted-by":"crossref","unstructured":"Berg EJ, Ying GS, Maguire MG, et al., DREAM Study Research Group. Climatic and environmental correlates of dry eye disease severity: a report from the Dry Eye Assessment and Management (DREAM) Study. Transl Vis Sci Technol. 2020;9(5):25.","DOI":"10.1167\/tvst.9.5.25"},{"issue":"3","key":"1129_CR92","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/diagnostics11030392","volume":"11","author":"E Chlasta-Twardzik","year":"2021","unstructured":"Chlasta-Twardzik E, G\u00f3recka-Nito\u0144 A, Nowi\u0144ska A, Wyl\u0119ga\u0142a E. The influence of work environment factors on the ocular surface in a one-year follow-up prospective clinical study. Diagnostics (Basel). 2021;11(3):392.","journal-title":"Diagnostics (Basel)"},{"key":"1129_CR93","doi-asserted-by":"crossref","unstructured":"Lemp MA. The mucin-deficient dry eye. Int Ophthalmol Clin. 1973;13(1):185\u2013189.","DOI":"10.1097\/00004397-197301310-00013"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01129-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T14:04:28Z","timestamp":1744898668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01129-8","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Arthur Cheng, Douglas Lam, Kelvin Chong, Kendrick Shih, and Kelvin H. Wan declare that they have received honorarium from Santen Pharmaceutical (Hong Kong) Limited for the advisory board meeting held to plan this manuscript. They have no other competing financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}